CASP3 and acute myeloid leukemia: It is highly active against Kasumi-1 AML cells (IC50 = 0.9 μM) and SkBr3 breast cancer cells (IC50 = 0.8 μM) and a potent apoptosis inducer by caspase-3/7 activation (IC50 = 1.2 μM) in MOLM13 AML cells.